Bhat Laxminarayan
Transaction: 03/18/2026
BUY
Change
+40,925
Price
$1.87
Filing
03/20/2026
Type
BUY
Reviva Pharmaceuticals Holdings, Inc.
RVPH • Biotechnology
$0.53
▼ -0.01 (-1.85%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$7.00M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 2.08Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:39 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.53
Change-1.85%
Shares Out13.21M
Market Cap$7.00M
Enterprise Value$-19.75T
52W Range0.26 - 17.20
Beta0.49
P/E-0.00
P/B0.00
P/FCF-0.00
EV/EBITDA7.54
EV/FCF3.34
Price$0.53
Change-1.85%
Shares Out13.21M
Market Cap$7.00M
Enterprise Value$-19.75T
52W Range0.26 - 17.20
Beta0.49
P/E-0.00
P/B0.00
P/FCF-0.00
EV/EBITDA7.54
EV/FCF3.34
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.05
Current Ratio2.08
Quick Ratio2.08
Volume22.00K
Avg Volume388.40K
EPS Surprise0.29
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 2.08Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
88/100
Bullish
Bullish
6
Hold
2
Bearish
0
Insider Transactions
Recent executive and insider activity
Prabhu Narayan
Transaction: 03/18/2026
BUY
Change
+40,925
Price
$1.87
Filing
03/20/2026
Type
BUY
SAXENA PARAG
Transaction: 12/18/2025
BUY
Change
+8,200
Price
$0.58
Filing
12/19/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Bhat Laxminarayan | BUY | +40,925 | $1.87 | 03/18/2026 | 03/20/2026 |
| Prabhu Narayan | BUY | +40,925 | $1.87 | 03/18/2026 | 03/20/2026 |
| SAXENA PARAG | BUY | +8,200 | $0.58 | 12/18/2025 | 12/19/2025 |
| Patel Purav | BUY | +8,200 | $0.58 | 12/18/2025 | 12/19/2025 |
| Margolin Richard A | BUY | +8,200 | $0.58 | 12/18/2025 | 12/19/2025 |
| Funtleyder Leslie D. | BUY | +8,200 | $0.58 | 12/18/2025 | 12/19/2025 |
| Bhat Laxminarayan | BUY | +181,500 | $1.80 | 02/13/2025 | 02/18/2025 |
| Narayan Prabhu | BUY | +194,250 | $1.80 | 02/13/2025 | 02/18/2025 |
| Margolin Richard A | BUY | +8,200 | $2.52 | 12/10/2024 | 12/12/2024 |
| Funtleyder Leslie D. | BUY | +8,200 | $2.52 | 12/10/2024 | 12/12/2024 |
| SAXENA PARAG | BUY | +8,200 | $2.52 | 12/10/2024 | 12/12/2024 |
| Patel Purav | BUY | +8,200 | $2.52 | 12/10/2024 | 12/12/2024 |
| Narayan Prabhu | BUY | +96,519 | $1.20 | 09/15/2024 | 09/17/2024 |
| Bhat Laxminarayan | BUY | +77,843 | $1.20 | 09/15/2024 | 09/17/2024 |
| SAXENA PARAG | BUY | +585,366 | $0.00 | 11/20/2023 | 11/22/2023 |
| SAXENA PARAG | BUY | +585,366 | $5.00 | 11/20/2023 | 11/22/2023 |
| Margolin Richard A | BUY | +8,200 | $6.04 | 11/13/2023 | 11/14/2023 |
| SAXENA PARAG | BUY | +8,200 | $6.04 | 11/13/2023 | 11/14/2023 |
| Patel Purav | BUY | +8,200 | $6.04 | 11/13/2023 | 11/14/2023 |
| Funtleyder Leslie D. | BUY | +8,200 | $6.04 | 11/13/2023 | 11/14/2023 |